Cardiac POC Testing Devices and Kits Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029

Evolution of cardiac point of care testing resulting from the application of innovative technology in medical science for improved disease diagnosis which further leads to betterment of cardiac health. Coronary artery diseases and ischemic heart diseases are on rise causing number of deaths worldwide with increasing geriatric population and changing lifestyle pattern; the rising trend of cardiac disorder drive the demand of POC testing devices for rapid and accurate health diagnosis. Diagnostic approach of acute coronary syndrome involves detection of elevated levels of certain biomarkers like cardiac troponin, creatine kinase (CK), CK-myocardial band (MB), B-type Natriuretic Peptide (BNP), myoglobin and help to make appropriate treatment decision.

Growing popularity of cardiac POC testing devices is owing to reduced time in sample processing and delivering accurate result. Overall growth of cardiac POC testing devices and kits market is a result of decreased turnaround time, increased patient safety and patient satisfaction. Shortage of trained health personnel in laboratories and wide ranges of Clinical Laboratory Improvement Amendments (CLIA)-waived POC testing devices contribute major growth to the cardiac POC testing devices and kits market. Technologically advanced and innovative products boost up the growth of cardiac POC testing devices and kits market. However, being comparatively expensive approach than traditional laboratory testing, growth of cardiac POC testing devices and kits market might get hampered. Stringent regulatory guidelines of POC devices and pricing pressure among major manufacturers might restrain the cardiac POC testing devices and kits market globally. This report contains the global cardiac POC testing devices and kits market in terms of devices type and geographical distribution. On the basis of device type, the cardiac POC testing kit was predicted to dominate the market owing to lower price and surging demand among health providers and the market size and forecast for each segment is presented for 2019-2029 along with respective CAGRs for the forecast duration 2021-2029.

The report titled ‘Cardiac POC Testing Devices and Kits Market - Growth, Future Prospects, and Competitive Analysis, 2021 - 2029’ is to provide company executives, investors, developers, and industry participants with profound analysis to take strategic initiatives and business decisions related to the present market scenario and future predictions of global cardiac POC testing devices and kits market. This report offers market trend of present and future market in the global cardiac POC testing devices and kits with detailed analysis of market size and forecast. Global health concern, increasing research expenditure, advanced technology and product innovation strongly boost up the growth of cardiac POC testing devices and kits market.

Geographically, the cardiac POC testing devices and kits market is segmented into five major regions and chief region level markets as follows:

• North America
• The United States
• Canada
• Europe
• The United Kingdom
• Germany
• Rest of Europe
• Asia Pacific
• Japan
• China
• India
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• Middle East and Africa
• Gulf Cooperation Council
• Rest of Middle East and Africa 

This research study encompasses market size and forecast data of every considered geographical market including constituent region/country for the period of 2019-2029 and presented with CAGRs for the forecast period 2021-2029.

This report also consists of qualitative factors which affect market dynamics such as market drivers, restraints and opportunities in order to attain an understanding of the global market trends of cardiac POC testing devices and kits. Detailed explanation of major agreements, mergers and acquisitions activities, joint venture, partnerships, collaborations and market attractiveness assessment have been mentioned in the study report. In addition, this report comprises competitive landscape analysis and profiling of major market players such as Nexus Dx, Inc., LifeSign LLC., Alfa Scientific Designs, Inc., Spectral Diagnostics, Roche Diagnostics International Ltd., American Screening Corporation, Inc., Alere, Abbott, Siemens Ltd., Mitsubishi Chemical, bioMérieux, Inc., Nano-Ditech Corp.

The cardiac POC testing devices and kits market is categorized on the basis of device types and the categories are:

• Cardiac POC testing analyzer
• Cardiac POC test kits
• Cardiac Troponin Biomarker Test
• Myoglobin Biomarker Test
• Brain Natriuretic Peptide (BNP) Test
• Creatine Kinase Myoglobin (CK-MB) Biomarker Test
• D-Dimer Test
• Hybrid Test

Cardiac POC test kits are estimated to dominate the cardiac POC testing device and kits market due to cheaper price and increasing trend of usage. Biochemical marker has crucial role in clinical diagnosis of medical condition such as acute myocardial infarction or cardiac injury when traditional method fails to detect. The concept of cardiac point of care diagnosis has been evolving with time as a result of fastest, accurate and reliable clinical outcomes. Cardiac POC testing devices provides advantage of lowering delay in sample transportation processing and data entry, which further boost POC testing device market to grow. Options of easy handling, portability of device, rapid result of detection and reduced period of hospital stay facilitates the growth of cardiac POC biomarker testing device. Cardiac analyzer is predicted to witness significant growth as a result of technologically advanced device features like barcode scanner, simple operation and low maintenance electrodes. 

Geographically, the global cardiac POC testing devices and kits market is cumulative to North America, Europe, Asia Pacific, Latin America and Middle East and Africa.

North America emerged as the leading region in cardiac POC testing devices and kits market with a steady growth owing to developed healthcare infrastructure, growing prevalence of chronic ailments and emerging health awareness among public with increasing personal income. Advancement in technology and absence of stringent regulation of POC procedures coupled with rapid paradigm shift towards self-care among patients with home-based testing options is further driving the cardiac POC testing and kits market in this region. However, healthcare reform and deceleration in economy in U.S. have affected the growth of the market. Europe is predicted to secure the second position due to increasing prevalence of chronic cardiac disorders, decentralized laboratories, surging acceptance of POC devices in clinical care set up and patient inclination to self-diagnosis. Cardiac POC testing devices resolves issues of patient admission in overcrowded hospital and shortage of proper skilled lab technician in these regions.

Asia Pacific is anticipated to witness fastest growth in upcoming years on account of emerging economies, steady growth of health awareness and developing healthcare infrastructure. Rising physician’s demand for POC procedures, growing preference for long term use of cardiac POC testing outside of professional setting and emerging regulatory guidelines are expected to fuel grow in this region in upcoming period.

The complete regional classification of the global cardiac POC testing devices and kits market is as follows:

• North America (U.S. & Canada)
• Europe (Germany, U.K., and Rest of Europe)
• Asia Pacific (China, India, Japan and Rest of Asia Pacific)
• Latin America (Brazil, Mexico, and Rest of Latin America)
• Middle East and Africa (GCC and Rest of Middle East and Africa)

This product will be delivered within 2 business days.